Late Outcomes for Aortic Valve Replacement With the Carpentier-Edwards Pericardial Bioprosthesis: Up to 17-Year Follow-Up in 1,000 Patients

被引:135
|
作者
McClure, R. Scott
Narayanasamy, Narendren
Wiegerinck, Esther
Lipsitz, Stuart
Maloney, Ann
Byrne, John G.
Aranki, Sary F.
Couper, Gregory S.
Cohn, Lawrence H. [1 ]
机构
[1] Brigham & Womens Hosp, Div Cardiac Surg, Boston, MA 02115 USA
来源
ANNALS OF THORACIC SURGERY | 2010年 / 89卷 / 05期
关键词
20-YEAR EXPERIENCE; DURABILITY;
D O I
10.1016/j.athoracsur.2010.01.046
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This study reviews a single institution experience with the Carpentier-Edwards pericardial aortic valve bioprosthesis, concentrating on late outcomes. Methods. From December 1991 to June 2002, 1,000 patients underwent aortic valve replacement with the Carpentier-Edwards pericardial valve (mean follow-up 6.01 +/- 3.56 years). The institutional database was reviewed. Follow-up data were acquired through telephone interviews and mail-in questionnaires. Time-toevent analyses were performed by the Kaplan-Meier method. Mean age was 74.1 years; 545 patients (54.5%) were male. Mean preoperative ejection fraction was 52.5%. Isolated aortic valve replacement occurred in 372 cases (37.2%). Combined aortic valve replacement with coronary artery bypass grafting occurred in 443 cases (44.3%). The remaining 185 patients (18.5%) underwent complex procedures with concomitant mitral, tricuspid, or arch repair. One hundred forty patients (14.0%) had prior aortic valve surgery. Follow-up was 99.4% complete. Results. Overall operative mortality was 7.2% (72 of 1,000). There were 503 late deaths (50.3%). Age-stratified survival at 15 years was 43.7% for patients less than 65 years of age; 18.2% for patients aged 65 to 75; and 9.4% for patients aged more than 75 years. There were 26 failed bioprostheses (2.6%) requiring reoperation. Structural valve deterioration was the cause in 13 of 26 cases (50%), endocarditis in 11 of 26 (42%), and perivalvular leak in 2 of 26 (7.6%). Age-stratified freedom from reoperation due to structural valve deterioration at 15 years was 34.7% for patients less than 65 years of age; 89.4% for patients aged 65 to 75; and 99.5% for patients aged more than 75 years. Conclusions. The Carpentier-Edwards pericardial bioprosthesis shows long-term durability with low rates of structural failure. (Ann Thorac Surg 2010;89:1410-6) (C) 2010 by The Society of Thoracic Surgeons
引用
收藏
页码:1410 / 1416
页数:7
相关论文
共 50 条
  • [21] Eight-year outcomes of aortic valve replacement with the Carpentier-Edwards PERIMOUNT Magna Ease valve
    Tsui, Steven
    Rosenbloom, Michael
    Abel, James
    Swanson, Jeffrey
    Haverich, Axel
    Zacharias, Joseph
    Schorlemmer, Gilbert
    Cohen, Gideon
    Moulton, Michael
    Lange, Ruediger
    JOURNAL OF CARDIAC SURGERY, 2022, 37 (12) : 4999 - 5010
  • [22] Long-Term Clinical Outcomes of the Carpentier-Edwards Perimount Pericardial Bioprosthesis in Chinese Patients with Single or Multiple Valve Replacement in Aortic, Mitral, or Tricuspid Positions
    Guo, Huiming
    Lu, Cong
    Huang, Huanlei
    Xie, Bin
    Liu, Jian
    Zheng, Shaoyi
    Fan, Ruixin
    Chen, Jimei
    Zhuang, Jian
    CARDIOLOGY, 2017, 138 (02) : 97 - 106
  • [23] Aortic Leaflet Replacement with Fresh Autologous Pericardium: At 17-Year Follow-Up
    Ge, Nan
    Xu, Ping
    Gao, Hongbo
    THORACIC AND CARDIOVASCULAR SURGEON, 2012, 60 (01): : 81 - 83
  • [24] Aortic Valve Replacement With the Medtronic Mosaic Bioprosthesis: A 13-Year Follow-Up
    Celiento, Michele
    Ravenni, Giacomo
    Milano, Aldo D.
    Pratali, Stefano
    Scioti, Giovanni
    Nardi, Carmela
    Bortolotti, Uberto
    ANNALS OF THORACIC SURGERY, 2012, 93 (02): : 510 - 515
  • [25] Outcomes of surgical aortic valve replacement using Carpentier-Edwards PERIMOUNT bioprosthesis series in elderly patients with severe aortic valve stenosis: a retrospective cohort study
    Nishioka, Naritomo
    Yamada, Akira
    Ujihira, Kosuke
    Iba, Yutaka
    Maruyama, Ryushi
    Hatta, Eiichiro
    Kurimoto, Yoshihiko
    Nakanishi, Katsuhiko
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2016, 64 (12) : 728 - 734
  • [26] Outcomes of surgical aortic valve replacement using Carpentier-Edwards PERIMOUNT bioprosthesis series in elderly patients with severe aortic valve stenosis: a retrospective cohort study
    Naritomo Nishioka
    Akira Yamada
    Kosuke Ujihira
    Yutaka Iba
    Ryushi Maruyama
    Eiichiro Hatta
    Yoshihiko Kurimoto
    Katsuhiko Nakanishi
    General Thoracic and Cardiovascular Surgery, 2016, 64 : 728 - 734
  • [27] Influence of coronary artery disease and functional class an long term survival after aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis
    Do, QB
    Pellerin, M
    Cartler, R
    Hebert, Y
    Page, P
    Perrault, LP
    Pelletier, LC
    CIRCULATION, 1999, 100 (18) : 459 - 459
  • [28] Outcome and follow-up of aortic valve replacement with the freestyle stentless bioprosthesis
    Kappetein, AP
    Braun, J
    Baur, LHB
    Prat, A
    Peels, K
    Hazekamp, MG
    Schoof, PH
    Huysmans, HA
    ANNALS OF THORACIC SURGERY, 2001, 71 (02): : 601 - 607
  • [29] Six-year follow-up of aortic valve reoperation rates: Carpentier-Edwards Perimount versus St. Jude Medical Trifecta
    Stubeda, Herman
    Aliter, Hashem
    Gainer, Ryan A.
    Theriault, Chris
    Doucette, Steve
    Hirsch, Gregory M.
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (12) : 3347 - 3353
  • [30] Mid-term follow-up after aortic valve replacement with the Carpentier Edwards Magna Ease prosthesis
    Taufiek K. Rajab
    Jason M. Ali
    Jules Hernández-Sánchez
    Jennifer Mackie
    Vincenzo Grimaudo
    Silvia Sinichino
    Christine Mills
    Bushra Rana
    John Dunning
    Yasir Abu-Omar
    Journal of Cardiothoracic Surgery, 15